11:30 - 12:00 µî·Ï
|
12:00 – 12:30 Hands-on (1)
|
12:30 – 13:50 °©»ó¼± ¿µ»óÀÇÇÐ: °ú°Å, ÇöÀç, ±×¸®°í ¹Ì·¡ ÁÂÀå : ÀÌÁØÇü(µ¿¾Æ´ëÇб³º´¿ø), ¾çÀϱÇ(Á¦ÁÖÇѶ󺴿ø)
|
1. Ưº°°¿¬: My experience of ethanol ablation for thyroid nodule
|
ÀÌÈ£±Ô(Á¦Áִ뺴¿ø)
|
2. °©¿µÈ¸ÀÇ ÇöÀç¿Í ¹Ì·¡: ¹«¾ùÀ» ÇÒ °ÍÀΰ¡?
|
³ªµ¿±Ô(ÈÞ¸Õ¿µ»óÀÇÇм¾ÅÍ)
|
3. ÃÊÀ½ÆÄ ±Þ¿©È ÇöȲ ¹× Àü¸Á
|
½ÉÁ¤¼®(À§µå½ÉÀÇ¿ø)
|
4. °©»ó¼± ¿µ»óÀÇÇÐ ¿Ü·¡ Áø·á ÇöȲ ¹× Àü¸Á
|
ÀÓÇö°æ(¼øõÇâ´ëÇб³ ¼¿ïº´¿ø)
|
5. KSThR-KJR-Ultrasonography collaboration
|
±è¼öÁø(´º°í·Áº´¿ø, ÈÞ¸Õ¿µ»óÀÇÇм¾ÅÍ)
|
6. Q & A
|
13:50 - 14:10 ÈÞ½Ä, Hands-on (2)
|
14:10 - 15:30 How can I improve my clinical practice? ÁÂÀå: ¹éÁ¤È¯(¼¿ï¾Æ»êº´¿ø), Á¶¼ºÈÖ(°¿ø´ëº´¿ø)
|
1. Technical Secret of FNA
|
ÀÌ¿µÈç(°í´ë¾È»êº´¿ø)
|
2. Technical Secret of CNB
|
Á¤¼Ò·É(¼¿ï¼º¸ðº´¿ø)
|
3. Technical Secret of RFA
|
¼ºÁø¿ë(´ë¸²¼º¸ðº´¿ø)
|
4. Key points of 2015 ATA guideline
|
±èÁöÈÆ(¼¿ï´ëº´¿ø)
|
5. Q & A
|
15:30 - 15:50 ÈÞ½Ä, Hands-on (3)
|
15:50 - 17:00 Controversial Issues (Panel Discussion) ÁÂÀå: ³ªµ¿±Ô(ÈÞ¸Õ¿µ»óÀÇÇм¾ÅÍ), Á¤¼Ò·É(¼¿ï¼º¸ðº´¿ø)
|
1. Management of low risk papillary thyroid microcarcinoma: Active surveillance vs Immediate surgery
|
¹ßÇ¥: ½ÅÁ¤Èñ(¼¿ï»ï¼ºº´¿ø)
|
ÆгÎ: °í¼ö¿¬(Á¦Áִ뺴¿ø), ÀÌâÀ±(±¹¸³¾Ï¼¾ÅÍ), À±Àοµ(°ºÏ»ï¼ºº´¿ø)
|
2. Potential clinical application of RFA
|
¹ßÇ¥: ¹é¼±¹Ì(³ª´®°ú Çູº´¿ø)
|
ÆгÎ: ÇѼö¿¬(¼¿ï»ï¼ºº´¿ø), ÃÖÀ±Á¤(°ºÏ»ï¼ºº´¿ø), À̱¤Èñ(»õ¿ì¸®³²»êº´¿ø)
|
3. Protocol of Thyroid CT
|
¹ßÇ¥: ÀÌÁ¤Çö(¼¿ï¾Æ»êº´¿ø)
|
ÆгÎ: ±è¼öÁø(¼¿ï´ëº´¿ø °³²¼¾ÅÍ), °í¸íÁÖ(Á¦Áִ뺴¿ø), ÀÌÀ¯Áø(ºÎ»ê¹éº´¿ø)
|
17:00 - 17:20 ÃÑȸ
|